Lupus and COVID-19:What You Need to Know Webcast on Video
April 3, 2020
The Lupus Research Alliance (LRA) hosted a live webcast April 2, 2020 on COVID-19 for people with...
Kenneth Farber
COVID-19 Update: A Message from LRA President & CEO
March 18, 2020
Dear Friends,
Your well-being is the utmost priority for all of us at the Lupus Research Alliance (LRA)....
The Lupus Research Alliance Partners with the National Kidney Foundation to Offer Course to Healthcare Professionals
November 12, 2019
The Lupus Research Alliance (LRA) is pleased to announce a new collaboration with the National Kidney Foundation...
New Study Partly Funded by LRA Reveals Novel Lupus Drug Targets
NEW YORK, NY – May 29. Researchers partly funded by the Lupus Research Alliance (LRA) have found possible new...
2019 Lupus Luminary Luncheon for Science Celebrates Women of Achievement for Lupus Awareness Month
NEW YORK, NY – May 7, 2019. The 10th annual Lupus Luminary Luncheon for Science honored the accomplishments of...
Benlysta Approved for Children 5-Years and Up
April 26, 2019
We are very pleased to share news from GlaxoSmithKline (GSK) that intravenous Benlysta (belimumab) was approved by...
Lupus Research Alliance and National Minority Quality Forum Release Recommendations to Advance New Lupus Treatments by Increasing Diversity in Clinical Trial Participation
NEW YORK, NY. March 14, 2019. The Lupus Research Alliance (LRA) and the National Minority Quality Forum (NMQF) today...